Previous Close | 5.96 |
Open | 5.93 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's Range | 5.86 - 5.97 |
52 Week Range | 5.60 - 8.71 |
Volume | |
Avg. Volume | 76,272 |
Market Cap | 111.761M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.72 (12.37%) |
Ex-Dividend Date | Apr 02, 2018 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for IHD
SCOTTSDALE, Ariz., March 15, 2022--Voya Investment Management, the asset management business of Voya Financial, Inc. (NYSE: VOYA), announced today the distributions on the common shares of three of its closed-end funds (each a "Fund" and collectively, the "Funds").
Pharmaceutical Industry Veteran Brings Broad Legal Expertise to Vaxart Senior Management Team SOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced the appointment of Edward B. Berg as the Company's first in-house General Counsel, effective today. Mr. Berg has practiced law for more than 30 years and has represented Fortune 500 and mid-cap companies in biotechnology, pharmaceuticals and life sciences. He joins Vaxart from BioMarin Pharmaceutic
Vaxart, Inc. ( NASDAQ:VXRT ) is possibly approaching a major achievement in its business, so we would like to shine...